Understanding how bladder cancer starts in veterans exposed to harmful substances
BCCMA: Basic and Translational Mechanisms of Cancer Initiation of the Urothelium in Veterans Exposed to Carcinogens: Defining the Molecular and Spatial Features of Carcinoma in situ of the Bladder
['FUNDING_OTHER'] · JESSE BROWN VA MEDICAL CENTER · NIH-10948909
This study is looking at how bladder cancer starts in veterans who have been exposed to harmful substances from smoking and military service, with the goal of finding new ways to prevent and treat the disease by understanding the early changes in their bodies.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JESSE BROWN VA MEDICAL CENTER (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-10948909 on ClinicalTrials.gov |
What this research studies
This research focuses on bladder cancer, particularly how it begins in the urothelium, which is the tissue lining the bladder, in veterans who have been exposed to carcinogens from smoking and military deployment. The project aims to identify genetic and molecular changes that occur at the early stages of bladder cancer, which could lead to better prevention and treatment strategies. By analyzing the immune response and the genetic landscape of early-stage tumors, the research seeks to develop new therapies and improve risk assessment for at-risk patients. The ultimate goal is to create effective screening methods to detect bladder cancer earlier when it is more treatable.
Who could benefit from this research
Good fit: Ideal candidates for this research are veterans who have been exposed to carcinogens and are at risk for developing bladder cancer.
Not a fit: Patients who have not been exposed to known carcinogens or who do not have a history of bladder cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and more effective treatment options for bladder cancer in veterans.
How similar studies have performed: Previous research has shown promise in understanding the molecular mechanisms of bladder cancer, but this specific approach focusing on veterans and early-stage detection is relatively novel.
Where this research is happening
CHICAGO, UNITED STATES
- JESSE BROWN VA MEDICAL CENTER — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MEEKS, JOSHUA JAMES — JESSE BROWN VA MEDICAL CENTER
- Study coordinator: MEEKS, JOSHUA JAMES
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.